ÂÜÀòÂÒÂ×

Jeremy Heidel is an experienced professional in the field of siRNA and oncology drug development, currently serving as an independent consultant since January 2009. Prior to this role, Jeremy held positions as Chief Scientific Officer and Senior Scientist at Calando Pharmaceuticals from June 2005 to December 2008. Jeremy's educational background includes a Ph.D. in Chemical Engineering from Caltech, obtained in 2005, and a Bachelor of Science degree in Chemical Engineering and Biology from the Massachusetts Institute of Technology, completed in 1999.